Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Liabilities and Shareholders Equity (2016 - 2025)

Lifevantage's Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $61.2 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 10.74% year-over-year to $61.2 million; the TTM value through Dec 2025 reached $271.9 million, up 8.09%, while the annual FY2025 figure was $72.0 million, 19.34% up from the prior year.
  • Liabilities and Shareholders Equity reached $61.2 million in Q4 2025 per LFVN's latest filing, down from $61.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $78.7 million in Q2 2021 to a low of $60.3 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $68.3 million, with a median of $67.7 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 43.54% in 2021, then decreased 10.74% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $72.2 million in 2021, then dropped by 6.11% to $67.8 million in 2022, then fell by 7.59% to $62.7 million in 2023, then increased by 9.32% to $68.5 million in 2024, then decreased by 10.74% to $61.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFVN's Liabilities and Shareholders Equity are $61.2 million (Q4 2025), $61.6 million (Q3 2025), and $72.0 million (Q2 2025).